Journal article icon

Journal article

Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.

Abstract:
Due to their rapid and highly selective nature, bioorthogonal chemistry reactions are attracting a significant amount of recent interest in the radiopharmaceutical community. Over the last few years, reactions of this type have found tremendous utility in the construction of new radiopharmaceuticals and as a method of bioconjugation. Furthermore, reports are beginning to emerge in which these reactions are also being applied in vivo to facilitate a novel pretargeting strategy for the imaging and therapy of cancer. The successful implementation of such an approach could lead to dramatic improvements in image quality, therapeutic index, and reduced radiation dose to non-target organs and tissues. This review will focus on the potential of various bioorthogonal chemistry reactions to be used successfully in such an approach.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author


Cancer Research UK More from this funder


Publisher:
e-Century Publishing
Journal:
American journal of nuclear medicine and molecular imaging More from this journal
Volume:
4
Issue:
2
Pages:
96-113
Publication date:
2014-01-01
EISSN:
2160-8407


Language:
English
Keywords:
Pubs id:
pubs:462854
UUID:
uuid:28cea8ed-3108-4032-8651-a483830dfbc1
Local pid:
pubs:462854
Source identifiers:
462854
Deposit date:
2015-11-19
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP